Literature DB >> 28600700

Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.

Rachel Silva-Smith1, Daniel A Sussman2.   

Abstract

Through germline multigene panel testing, we discovered the co-occurrence of Lynch syndrome due to a PMS2 mutation and juvenile polyposis syndrome due to a BMPR1A mutation in a young man with synchronous bladder and colorectal cancers and a family history of colorectal polyps. To our knowledge, this is the first report of an individual having these two hereditary colorectal cancer syndromes. This discovery highlights the benefit of multigene testing over traditional stepwise genetic testing, particularly when a clinical presentation suggests more than one underlying genetic cause. This report adds to the growing body of literature of individuals with multiple inherited cancer gene defects being identified thanks to the increasing implementation of multigene panels with next generation sequencing technologies.

Entities:  

Keywords:  BMPR1A; Juvenile polyposis syndrome; Lynch syndrome; Multigene panel testing; Multilocus inherited neoplasia alleles syndrome; PMS2

Mesh:

Substances:

Year:  2018        PMID: 28600700     DOI: 10.1007/s10689-017-0012-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  11 in total

1.  Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.

Authors:  Tom Walsh; Silvia Casadei; Ming K Lee; Christopher C Pennil; Alex S Nord; Anne M Thornton; Wendy Roeb; Kathy J Agnew; Sunday M Stray; Anneka Wickramanayake; Barbara Norquist; Kathryn P Pennington; Rochelle L Garcia; Mary-Claire King; Elizabeth M Swisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

Authors:  Susan M Domchek; Angela Bradbury; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2013-03-04       Impact factor: 44.544

3.  Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.

Authors:  Nadine Tung; Chiara Battelli; Brian Allen; Rajesh Kaldate; Satish Bhatnagar; Karla Bowles; Kirsten Timms; Judy E Garber; Christina Herold; Leif Ellisen; Jill Krejdovsky; Kim DeLeonardis; Kristin Sedgwick; Kathleen Soltis; Benjamin Roa; Richard J Wenstrup; Anne-Renee Hartman
Journal:  Cancer       Date:  2014-09-03       Impact factor: 6.860

4.  Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.

Authors:  Carlos J Gallego; Brian H Shirts; Caroline S Bennette; Greg Guzauskas; Laura M Amendola; Martha Horike-Pyne; Fuki M Hisama; Colin C Pritchard; William M Grady; Wylie Burke; Gail P Jarvik; David L Veenstra
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

5.  Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

Authors:  Matthew B Yurgelun; Brian Allen; Rajesh R Kaldate; Karla R Bowles; Thaddeus Judkins; Praveen Kaushik; Benjamin B Roa; Richard J Wenstrup; Anne-Renee Hartman; Sapna Syngal
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

Review 6.  Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and Review.

Authors:  James Whitworth; Anne-Bine Skytte; Lone Sunde; Derek H Lim; Mark J Arends; Lisa Happerfield; Ian M Frayling; Rick van Minkelen; Emma R Woodward; Marc D Tischkowitz; Eamonn R Maher
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

7.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Authors:  Leigha Senter; Mark Clendenning; Kaisa Sotamaa; Heather Hampel; Jane Green; John D Potter; Annika Lindblom; Kristina Lagerstedt; Stephen N Thibodeau; Noralane M Lindor; Joanne Young; Ingrid Winship; James G Dowty; Darren M White; John L Hopper; Laura Baglietto; Mark A Jenkins; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-05-02       Impact factor: 22.682

8.  Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

Authors:  Yvonne M C Hendriks; Shantie Jagmohan-Changur; Heleen M van der Klift; Hans Morreau; Marjo van Puijenbroek; Carli Tops; Theo van Os; Anja Wagner; Margreet G F M Ausems; Encarna Gomez; Martijn H Breuning; Annette H J T Bröcker-Vriends; Hans F A Vasen; Juul Th Wijnen
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

9.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

10.  Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.

Authors:  Lisa R Susswein; Megan L Marshall; Rachel Nusbaum; Kristen J Vogel Postula; Scott M Weissman; Lauren Yackowski; Erica M Vaccari; Jeffrey Bissonnette; Jessica K Booker; M Laura Cremona; Federica Gibellini; Patricia D Murphy; Daniel E Pineda-Alvarez; Guido D Pollevick; Zhixiong Xu; Gabi Richard; Sherri Bale; Rachel T Klein; Kathleen S Hruska; Wendy K Chung
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

View more
  2 in total

1.  Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.

Authors:  Ido Laish; Eitan Friedman; Gili Levi-Reznick; Inbal Kedar; Lior Katz; Zohar Levi; Naama Halpern; Shani Parnasa; Aasem Abu-Shatya; Elizabeth Half; Yael Goldberg
Journal:  Breast Cancer Res Treat       Date:  2021-06-04       Impact factor: 4.872

2.  Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?

Authors:  Agostina Stradella; Jesús Del Valle; Paula Rofes; Lídia Feliubadaló; Èlia Grau Garces; Àngela Velasco; Sara González; Gardenia Vargas; Ángel Izquierdo; Olga Campos; Eva Tornero; Matilde Navarro; Judith Balmaña-Gelpi; Gabriel Capellá; Marta Pineda; Joan Brunet; Conxi Lázaro
Journal:  J Med Genet       Date:  2018-12-22       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.